In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain

Paul Cumming, Ariel Ase, Christine Laliberté, Hiroto Kuwabara, Albert Gjedde

Research output: Contribution to journalArticle

Abstract

To test the hypothesis that dopamine (DA) receptors influence cerebral DOPA-decarboxylase (DDC) activity in vivo, we used HPLC to measure the kinetics of the cerebral uptake and metabolism of [3H]DOPA in carbidopa- treated rats, and in rats also treated acutely with a DA receptor antagonist (flupenthixol, 2 mg/kg, intraperitoneally) or a DA receptor agonist (apomorphine, 200 μg/g, subcutaneously). The unidirectional blood-brain clearance of [3H]DOPA (K1(DOPA), 0.030 mL g-1 min-1) increased by 50% after flupenthixol. The magnitudes of the relative DDC activity (k3(DOPA) in striatum (0.20 min-1), olfactory tubercle (0.11 min-1), and hypothalamus (0.15 min-1) of carbidopa-treated rats were doubled with flupenthixol, but conical DDC activity was unaffected (0.02 min-1). Apomorphine reduced the magnitude of k3(DOPA) in striatum by 20%. The rate constant for catabolism of [3H]DA formed in brain (k7', monoamine oxidase [MAO] activity), which ranged from 0.025 min-1 in striatum to 0.08 min-1 in hypothalamus of carbidopa-treated rats, globally increased 2- to 4-fold after flupenthixol, and decreased to 0.003 min-1 in striatum after apomorphine. These in vivo results confirm the claim that acute blockade of DA receptors with flupenthixol stimulates the synthesis of [3H]DA from [3H]DOPA, and that this [3H]DA is subject to accelerated catabolism. Conversely, activation of the DA receptors with apomorphine inhibits DDC activity and DA catabolism.

Original languageEnglish (US)
Pages (from-to)1254-1260
Number of pages7
JournalJournal of Cerebral Blood Flow and Metabolism
Volume17
Issue number11
StatePublished - Nov 1997
Externally publishedYes

Fingerprint

Flupenthixol
Carboxy-Lyases
Dopamine Receptors
Apomorphine
Carbidopa
Dopamine
Brain
Hypothalamus
Dopamine Antagonists
Dopamine Agonists
Monoamine Oxidase
High Pressure Liquid Chromatography

Keywords

  • Agonists
  • Antagonists
  • Apomorphine
  • DOPA
  • DOPA decarboxylase
  • Flupenthi xol
  • Kinetics
  • Neuroleptics
  • Regulation

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)
  • Endocrinology, Diabetes and Metabolism

Cite this

In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain. / Cumming, Paul; Ase, Ariel; Laliberté, Christine; Kuwabara, Hiroto; Gjedde, Albert.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 17, No. 11, 11.1997, p. 1254-1260.

Research output: Contribution to journalArticle

Cumming, P, Ase, A, Laliberté, C, Kuwabara, H & Gjedde, A 1997, 'In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain', Journal of Cerebral Blood Flow and Metabolism, vol. 17, no. 11, pp. 1254-1260.
Cumming, Paul ; Ase, Ariel ; Laliberté, Christine ; Kuwabara, Hiroto ; Gjedde, Albert. / In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain. In: Journal of Cerebral Blood Flow and Metabolism. 1997 ; Vol. 17, No. 11. pp. 1254-1260.
@article{0c2fc9b26fd4453da865061ec096ffbd,
title = "In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain",
abstract = "To test the hypothesis that dopamine (DA) receptors influence cerebral DOPA-decarboxylase (DDC) activity in vivo, we used HPLC to measure the kinetics of the cerebral uptake and metabolism of [3H]DOPA in carbidopa- treated rats, and in rats also treated acutely with a DA receptor antagonist (flupenthixol, 2 mg/kg, intraperitoneally) or a DA receptor agonist (apomorphine, 200 μg/g, subcutaneously). The unidirectional blood-brain clearance of [3H]DOPA (K1(DOPA), 0.030 mL g-1 min-1) increased by 50{\%} after flupenthixol. The magnitudes of the relative DDC activity (k3(DOPA) in striatum (0.20 min-1), olfactory tubercle (0.11 min-1), and hypothalamus (0.15 min-1) of carbidopa-treated rats were doubled with flupenthixol, but conical DDC activity was unaffected (0.02 min-1). Apomorphine reduced the magnitude of k3(DOPA) in striatum by 20{\%}. The rate constant for catabolism of [3H]DA formed in brain (k7', monoamine oxidase [MAO] activity), which ranged from 0.025 min-1 in striatum to 0.08 min-1 in hypothalamus of carbidopa-treated rats, globally increased 2- to 4-fold after flupenthixol, and decreased to 0.003 min-1 in striatum after apomorphine. These in vivo results confirm the claim that acute blockade of DA receptors with flupenthixol stimulates the synthesis of [3H]DA from [3H]DOPA, and that this [3H]DA is subject to accelerated catabolism. Conversely, activation of the DA receptors with apomorphine inhibits DDC activity and DA catabolism.",
keywords = "Agonists, Antagonists, Apomorphine, DOPA, DOPA decarboxylase, Flupenthi xol, Kinetics, Neuroleptics, Regulation",
author = "Paul Cumming and Ariel Ase and Christine Lalibert{\'e} and Hiroto Kuwabara and Albert Gjedde",
year = "1997",
month = "11",
language = "English (US)",
volume = "17",
pages = "1254--1260",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain

AU - Cumming, Paul

AU - Ase, Ariel

AU - Laliberté, Christine

AU - Kuwabara, Hiroto

AU - Gjedde, Albert

PY - 1997/11

Y1 - 1997/11

N2 - To test the hypothesis that dopamine (DA) receptors influence cerebral DOPA-decarboxylase (DDC) activity in vivo, we used HPLC to measure the kinetics of the cerebral uptake and metabolism of [3H]DOPA in carbidopa- treated rats, and in rats also treated acutely with a DA receptor antagonist (flupenthixol, 2 mg/kg, intraperitoneally) or a DA receptor agonist (apomorphine, 200 μg/g, subcutaneously). The unidirectional blood-brain clearance of [3H]DOPA (K1(DOPA), 0.030 mL g-1 min-1) increased by 50% after flupenthixol. The magnitudes of the relative DDC activity (k3(DOPA) in striatum (0.20 min-1), olfactory tubercle (0.11 min-1), and hypothalamus (0.15 min-1) of carbidopa-treated rats were doubled with flupenthixol, but conical DDC activity was unaffected (0.02 min-1). Apomorphine reduced the magnitude of k3(DOPA) in striatum by 20%. The rate constant for catabolism of [3H]DA formed in brain (k7', monoamine oxidase [MAO] activity), which ranged from 0.025 min-1 in striatum to 0.08 min-1 in hypothalamus of carbidopa-treated rats, globally increased 2- to 4-fold after flupenthixol, and decreased to 0.003 min-1 in striatum after apomorphine. These in vivo results confirm the claim that acute blockade of DA receptors with flupenthixol stimulates the synthesis of [3H]DA from [3H]DOPA, and that this [3H]DA is subject to accelerated catabolism. Conversely, activation of the DA receptors with apomorphine inhibits DDC activity and DA catabolism.

AB - To test the hypothesis that dopamine (DA) receptors influence cerebral DOPA-decarboxylase (DDC) activity in vivo, we used HPLC to measure the kinetics of the cerebral uptake and metabolism of [3H]DOPA in carbidopa- treated rats, and in rats also treated acutely with a DA receptor antagonist (flupenthixol, 2 mg/kg, intraperitoneally) or a DA receptor agonist (apomorphine, 200 μg/g, subcutaneously). The unidirectional blood-brain clearance of [3H]DOPA (K1(DOPA), 0.030 mL g-1 min-1) increased by 50% after flupenthixol. The magnitudes of the relative DDC activity (k3(DOPA) in striatum (0.20 min-1), olfactory tubercle (0.11 min-1), and hypothalamus (0.15 min-1) of carbidopa-treated rats were doubled with flupenthixol, but conical DDC activity was unaffected (0.02 min-1). Apomorphine reduced the magnitude of k3(DOPA) in striatum by 20%. The rate constant for catabolism of [3H]DA formed in brain (k7', monoamine oxidase [MAO] activity), which ranged from 0.025 min-1 in striatum to 0.08 min-1 in hypothalamus of carbidopa-treated rats, globally increased 2- to 4-fold after flupenthixol, and decreased to 0.003 min-1 in striatum after apomorphine. These in vivo results confirm the claim that acute blockade of DA receptors with flupenthixol stimulates the synthesis of [3H]DA from [3H]DOPA, and that this [3H]DA is subject to accelerated catabolism. Conversely, activation of the DA receptors with apomorphine inhibits DDC activity and DA catabolism.

KW - Agonists

KW - Antagonists

KW - Apomorphine

KW - DOPA

KW - DOPA decarboxylase

KW - Flupenthi xol

KW - Kinetics

KW - Neuroleptics

KW - Regulation

UR - http://www.scopus.com/inward/record.url?scp=0030732676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030732676&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 1254

EP - 1260

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 11

ER -